MSSPT PEPTIDE PEN LIMITLESS – R1600

Limitless combines three synergistic compounds that target cellular energy, mitochondrial function, and metabolic regulation: 

• NAD* (Nicotinamide Adenine Dinucleotide): A critical coenzyme present in all living cells. It exists in oxidized (NAD*) and reduced (NADH) forms. 
• MOTS-C: A 16-amino-acid mitochondrial-derived peptide (MDP). Sequence: MRWQEMGYIFYPRKLR. 
• 5-Amino-1MQ: A small-molecule quinolinium derivative (5-amino-1-methylquinolinium).

Mechanism of Action 

• NAD* serves as a substrate for sirtuins (SIRT1-7), PARPS, and CD38, regulating DNA repair, mitochondrial biogenesis, circadian rhythm, inflammation, and cellular senescence. Supplementation elevates NAD* levels, restoring sirtuin activity, enhancing mitochondrial efficiency, and supporting energy metabolism. 
• MOTS-C acts as a retrograde mitochondrial signal. It activates AMPK, promotes PGC-1a expression, increases fatty acid oxidation, improves insulin sensitivity, enhances metabolic flexibility, and protects against age- and diet-induced metabolic dysfunction. 
• 5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it reduces 1- methylnicotinamide production, preserves nicotinamide for NAD* synthesis, increases intracellular NAD*, shifts metabolism toward oxidative pathways, reduces fat storage, and enhances mitochondrial function and energy expenditure. 

The triple combination works synergistically to elevate NAD* pools, optimize mitochondrial performance, improve metabolic efficiency, reduce adipose accumulation, and support cellular resilience and longevity pathways. 

Indications & Usage 

Limitless is used to support cellular energy, metabolic health, and longevity processes. It is indicated for: 

• Enhancement of mitochondrial function and energy production 
• Promotion of fat oxidation and healthy body composition 
• Support for metabolic flexibility and insulin sensitivity 
• Assistance in cellular repair, resilience, and anti-aging metabolic pathways 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to NAD*, MOTS-C, 5-Amino-1MQ, or any excipient Active malignancy or history of cancer 
• Severe uncontrolled diabetes mellitus or insulin resistance syndromes 
• Severe hepatic or renal impairment 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision with regular monitoring (glucose, lipids, liver function, and clinical parameters). 
• Not a substitute for diet, exercise, or approved medical therapies for metabolic disorders or obesity. Potential for glucose intolerance or transient changes in energy/blood pressure. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., rapid heartbeat, severe headache, chest pain, or signs of allergic reaction). 

Dosage & Administration 

• Subcutaneous injection only. 
• 5 Clicks (Light / Entry Protocol): 5 mg total actives (NAD* ~4.17 mg/MOTS-C≈0.42 mg/5-Amino-1MQ ≈0.42 mg) – yields 48 doses 
• 10 Clicks (Standard Performance / Longevity): 10 mg total actives (NAD*~8.33 mg/MOTS-C ~0.83 mg/5-Amino-1MQ ~0.83 mg) – yields 24 doses 
• 12 Clicks (Optimized Weekly Protocol): 12 mg total actives (NAD* ~10.0 mg/MOTS-C 1.0 mg/5-Amino-1MQ ≈1.0 mg) – yields 20 doses 
• 20 Clicks (Advanced Metabolic Protocol): 20 mg total actives (NAD* ~16.7 mg/MOTS-C≈1.67 mg/5-Amino-1MQ ~1.67 mg)-yields 12 doses 
• Frequency: Once daily (consistent timing recommended) 
• Timing: Morning (preferred for energy/metabolic support) or evening (for recovery/sleep quality) 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks. 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

The Limitless combination is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection-site irritation, redness, or itching 
• Transient headache, light-headedness, or flushing 
• Temporary changes in energy levels, appetite, or sleep pattern during initial use 
• Rare mild gastrointestinal discomfort or nausea 
• Rare restlessness or mild palpitations (dose-related) 
• If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, breathing difficulty, or allergic signs), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.